# Nuclide record dosimetry-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/roadmaps/dosimetry-roadmap/>
  a schema:CreativeWork ;
  nuclide:kind "roadmap" ;
  schema:identifier "dosimetry-roadmap" ;
  schema:name "Dosimetry roadmap: MIRD schema → fixed dosing → personalised, image-based dose"@en ;
  schema:description "Working out how much radiation a treatment actually delivers to a tumour and to healthy organs, rather than just giving everyone the same fixed amount, could let doctors treat some patients more and some less. The tools to do this patient by patient exist and are used in some specialist centres, but most approved radioligand therapies are still given at one fixed dose to everyone."@en ;
  schema:url <https://nuclide.cc/roadmaps/dosimetry-roadmap/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://jnm.snmjournals.org/content/jnumed/50/2/25N.full.pdf>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC5506097/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC10317889/> ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioligand-dosimetry/>, <https://nuclide.cc/technologies/in-vivo-dosimetry/>, <https://nuclide.cc/technologies/spect-ct/>, <https://nuclide.cc/technologies/total-body-pet-screening/> ;
  nuclide:terms <https://nuclide.cc/terms/dosimetry/>, <https://nuclide.cc/terms/gray-unit/> ;
  nuclide:trials <https://nuclide.cc/trials/netter-1/>, <https://nuclide.cc/trials/vision/> ;
  nuclide:people <https://nuclide.cc/people/clemens-kratochwil/>, <https://nuclide.cc/people/ken-herrmann/> .
